David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
CALL
Allegion
ALLE
$13.8B
| $377K | ﹤0.01% |
6,171
-5,511
| -47% | -$315K |
|
3177
NVE Corp
NVEC
$516M
| $377K | ﹤0.01% |
5,466
+300
| +6% | +$19.9K |
|
3178
CALL
Sysco
SYY
$40.2B
| $377K | ﹤0.01% |
+10,000
| New | +$394K |
|
3179
United Natural Foods
UNFI
$2.9B
| $377K | ﹤0.01% |
+4,893
| New | +$383K |
|
|
GLOG
3180
DELISTED
GASLOG LTD
GLOG
| $377K | ﹤0.01% |
19,402
-18,400
| -49% | -$346K |
|
|
STR
3181
DELISTED
QUESTAR CORP
STR
| $377K | ﹤0.01% |
15,810
-51,268
| -76% | -$1.25M |
|
|
AVNS
3182
CALL
DELISTED
Avanos Medical
AVNS
| $375K | ﹤0.01% |
7,620
| – | – |
|
3183
Copa Holdings
CPA
$6.05B
| $374K | ﹤0.01% |
3,700
-5,600
| -60% | -$608K |
|
3184
Forrester Research
FORR
$230M
| $373K | ﹤0.01% |
10,132
+2,414
| +31% | +$90.5K |
|
3185
Axos Financial
AX
$5.62B
| $372K | ﹤0.01% |
+16,000
| New | +$352K |
|
3186
Hasbro
HAS
$13.7B
| $372K | ﹤0.01% |
5,885
-9,500
| -62% | -$558K |
|
3187
Heritage Insurance Holdings
HRTG
$1.02B
| $370K | ﹤0.01% |
+16,792
| New | +$340K |
|
3188
HUB Group
HUBG
$2.43B
| $370K | ﹤0.01% |
+18,848
| New | +$355K |
|
3189
PUT
NVIDIA
NVDA
$5.12T
| $370K | ﹤0.01% |
708,000
-1,036,000
| -59% | -$551K |
|
3190
TRX Gold Corp
TRX
$393M
| $370K | ﹤0.01% |
1,058,229
-146,738
| -12% | -$76.2K |
|
|
PIR
3191
DELISTED
Pier 1 Imports, Inc.
PIR
| $370K | ﹤0.01% |
1,325
-22,119
| -94% | -$6.4M |
|
3192
Fortinet
FTNT
$115B
| $369K | ﹤0.01% |
52,720
-168,165
| -76% | -$1.1M |
|
3193
Madrigal Pharmaceuticals
MDGL
$11.9B
| $369K | ﹤0.01% |
5,434
-4,780
| -47% | -$410K |
|
3194
Wolfspeed
WOLF
$1.39B
| $368K | ﹤0.01% |
10,362
-155,109
| -94% | -$5.6M |
|
|
BKCC
3195
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $367K | ﹤0.01% |
40,469
+13,257
| +49% | +$114K |
|
|
TTPH
3196
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $366K | ﹤0.01% |
+500
| New | +$376K |
|
|
ATRS
3197
DELISTED
Antares Pharma, Inc.
ATRS
| $365K | ﹤0.01% |
134,509
+28,511
| +27% | +$72.3K |
|
3198
COPT Defense Properties
CDP
$4.28B
| $364K | ﹤0.01% |
12,382
-24,124
| -66% | -$713K |
|
3199
Landstar System
LSTR
$6.05B
| $363K | ﹤0.01% |
+5,470
| New | +$371K |
|
3200
Federated Hermes
FHI
$4.85B
| $362K | ﹤0.01% |
10,670
-20,749
| -66% | -$689K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.